Related Experiment Videos

[Screening of tetrahydrobiopterin deficiency among hyperphenylalaninemic patients]

J L Dhondt1, J M Hayte

  • 1Laboratoire de biochimie, Hôpital Saint-Philibert, 115, rue du Grand-But, 59462 Lomme cedex.

Insights

Rapid screening for tetrahydrobiopterin deficiency in newborns with hyperphenylalaninemia is crucial. A simple filter paper method detects deficiencies, enabling timely, specific follow-up for affected infants.

Area of Science:

  • Biochemistry
  • Genetics
  • Neonatal screening

Context:

  • Hyperphenylalaninemia in newborns requires prompt diagnosis.
  • Tetrahydrobiopterin (BH4) deficiency is a treatable metabolic disorder.
  • Early detection of BH4 deficiency is critical for proper patient management.

Purpose:

  • To evaluate a long-standing screening strategy for tetrahydrobiopterin deficiencies.
  • To assess the efficacy of a simple, filter paper-based method for detecting BH4 deficiencies in neonates.
  • To analyze the prevalence of BH4 deficiencies among screened hyperphenylalaninemic infants.

Summary:

  • A screening strategy utilizing urine pteridine and dried blood enzyme measurements has been employed since 1987.
  • This method effectively detects deficiencies in 6-pyruvoyl-tetrahydropterin synthase, GTPcyclohydrolase I, pterin-4a-carbinolamine dehydratase, and dihydropteridine-reductase.
  • Out of 1,814 hyperphenylalaninemic patients studied, 34 cases of tetrahydrobiopterin deficiency were identified.

Impact:

  • The described screening strategy is convenient and simple for widespread neonatal application.
  • It allows for the detection of BH4 deficiencies regardless of the initial blood phenylalanine level.
  • This approach facilitates essential, disease-specific follow-up for affected infants, improving outcomes.

Related Concept Videos